Multiple Sclerosis: Insights Into Optimal Care
All patients are not equal when it comes to diagnosis and prognosis of MS. Learn new approaches to personalize treatments and optimize patient QOL.
All patients are not equal when it comes to diagnosis and prognosis of MS. Learn new approaches to personalize treatments and optimize patient QOL.
Incidence of stroke was significantly higher among Indigenous people in affluent countries than their non-Indigenous counterparts.
Clinicians have often advised patients with migraine to avoid caffeine, which is seen as a potential headache trigger. This study found no such association.
Playing a musical instrument or singing in a musical group was associated with better working memory and executive function, new study results showed.
Some US veterans diagnosed with dementia may have undiagnosed advanced fibrosis or cirrhosis that could explain their cognitive impairment.
Flavonoids have been proposed as an approach to reducing Parkinson’s disease risk, but new data showed no association of flavonoid intake with protective benefit.
Results from a mouse model could lead to the development of therapies to prevent neurologic damage caused by viruses such as Zika.
The STOP-CAD study signaled a short course of an antithrombotic regimen might lower ischemic stroke risk in some patients without significantly increasing major bleeding.
Three new randomized trials, EMBOLISE, MAGIC-MT, and STEM, showed convincing benefits for use of an endovascular embolization procedure in patients with a subdural hematoma.
It takes 10 to 16 months to diagnose amyotrophic lateral sclerosis (ALS), resulting in precious time lost in slowing down the disease progression.
Intravenous tirofiban over 72 hours reduced early neurologic deterioration compared with oral aspirin in patients with acute ischemic stroke, in the randomized TREND trial.